Upgrade to SI Premium - Free Trial

Solventum (SOLV) PT Raised to $102 at KeyBanc

August 6, 2026 5:32 AM
KeyBanc analyst Brett Fishbin raised the price target on Solventum (NYSE: SOLV) to $102.00 (from $93.00) while maintaining a Overweight rating.

Categories

Analyst PT Change